199 related articles for article (PubMed ID: 37245738)
1. Impact of controlled ice nucleation and lyoprotectants on nanoparticle stability during Freeze-drying and upon storage.
Luo WC; Zhang W; Kim R; Chong H; Patel SM; Bogner RH; Lu X
Int J Pharm; 2023 Jun; 641():123084. PubMed ID: 37245738
[TBL] [Abstract][Full Text] [Related]
2. Impact of formulation on the quality and stability of freeze-dried nanoparticles.
Luo WC; O'Reilly Beringhs A; Kim R; Zhang W; Patel SM; Bogner RH; Lu X
Eur J Pharm Biopharm; 2021 Dec; 169():256-267. PubMed ID: 34732383
[TBL] [Abstract][Full Text] [Related]
3. 100% Control of Controlled Ice Nucleation Vials by Camera-Supported Optical Inspection in Freeze-Drying.
Lenger JH; Geidobler R; Halbinger W; Presser I; Winter G
PDA J Pharm Sci Technol; 2022; 76(2):120-135. PubMed ID: 34131013
[TBL] [Abstract][Full Text] [Related]
4. Effect of controlled ice nucleation on primary drying stage and protein recovery in vials cooled in a modified freeze-dryer.
Passot S; Tréléa IC; Marin M; Galan M; Morris GJ; Fonseca F
J Biomech Eng; 2009 Jul; 131(7):074511. PubMed ID: 19640147
[TBL] [Abstract][Full Text] [Related]
5. Stability of Freeze-Dried Protein Formulations: Contributions of Ice Nucleation Temperature and Residence Time in the Freeze-Concentrate.
Fang R; Bogner RH; Nail SL; Pikal MJ
J Pharm Sci; 2020 Jun; 109(6):1896-1904. PubMed ID: 32112825
[TBL] [Abstract][Full Text] [Related]
6. Controlled nucleation in freeze-drying: effects on pore size in the dried product layer, mass transfer resistance, and primary drying rate.
Konstantinidis AK; Kuu W; Otten L; Nail SL; Sever RR
J Pharm Sci; 2011 Aug; 100(8):3453-3470. PubMed ID: 21465488
[TBL] [Abstract][Full Text] [Related]
7. Effect of Controlled Ice Nucleation on Stability of Lactate Dehydrogenase During Freeze-Drying.
Fang R; Tanaka K; Mudhivarthi V; Bogner RH; Pikal MJ
J Pharm Sci; 2018 Mar; 107(3):824-830. PubMed ID: 29074380
[TBL] [Abstract][Full Text] [Related]
8. Investigations on polyplex stability during the freezing step of lyophilization using controlled ice nucleation--the importance of residence time in the low-viscosity fluid state.
Kasper JC; Pikal MJ; Friess W
J Pharm Sci; 2013 Mar; 102(3):929-46. PubMed ID: 23280536
[TBL] [Abstract][Full Text] [Related]
9. Formulation, process, and storage strategies for lyophilizates of lipophilic nanoparticulate systems established based on the two models paliperidone palmitate and solid lipid nanoparticles.
Trenkenschuh E; Savšek U; Friess W
Int J Pharm; 2021 Sep; 606():120929. PubMed ID: 34303819
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of Controlled Ice Nucleation Techniques for Freeze-Drying of a Therapeutic Antibody.
Gitter JH; Geidobler R; Presser I; Winter G
J Pharm Sci; 2018 Nov; 107(11):2748-2754. PubMed ID: 30055225
[TBL] [Abstract][Full Text] [Related]
11. Devitrification of lyoprotectants: A critical determinant for bacteriophages inactivation in freeze-drying and storage.
Zheng H
Food Res Int; 2023 Nov; 173(Pt 1):113307. PubMed ID: 37803616
[TBL] [Abstract][Full Text] [Related]
12. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the different phases of the freeze-drying process of solid lipid nanoparticles using experimental designs.
Elbrink K; Van Hees S; Holm R; Kiekens F
Int J Pharm; 2023 Mar; 635():122717. PubMed ID: 36781084
[TBL] [Abstract][Full Text] [Related]
14. Freeze-dried nanocrystal dispersion of novel deuterated pyrazoloquinolinone ligand (DK-I-56-1): Process parameters and lyoprotectant selection through the stability study.
Mitrović JR; Bjelošević Žiberna M; Vukadinović A; Knutson DE; Sharmin D; Kremenović A; Ahlin Grabnar P; Planinšek O; Lunter D; Cook JM; Savić MM; Savić SD
Eur J Pharm Sci; 2023 Oct; 189():106557. PubMed ID: 37544333
[TBL] [Abstract][Full Text] [Related]
15. Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying.
Doktorovova S; Shegokar R; Fernandes L; Martins-Lopes P; Silva AM; Müller RH; Souto EB
Pharm Dev Technol; 2014 Dec; 19(8):922-9. PubMed ID: 24099511
[TBL] [Abstract][Full Text] [Related]
16. Reduced pressure ice fog technique for controlled ice nucleation during freeze-drying.
Patel SM; Bhugra C; Pikal MJ
AAPS PharmSciTech; 2009; 10(4):1406-11. PubMed ID: 19937284
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Two Different Pressure-Based Controlled Ice Nucleation Techniques in Freeze-Drying: The Integral Role of Shelf Temperature After Nucleation in Process Performance and Product Quality.
Wenzel T; Gieseler M; Gieseler H
J Pharm Sci; 2020 Sep; 109(9):2746-2756. PubMed ID: 32497596
[TBL] [Abstract][Full Text] [Related]
18. Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery.
Ngamcherdtrakul W; Sangvanich T; Reda M; Gu S; Bejan D; Yantasee W
Int J Nanomedicine; 2018; 13():4015-4027. PubMed ID: 30022824
[TBL] [Abstract][Full Text] [Related]
19. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
20. Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization.
Ball RL; Bajaj P; Whitehead KA
Int J Nanomedicine; 2017; 12():305-315. PubMed ID: 28115848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
